| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |